UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000013206 |
|---|---|
| Receipt number | R000015333 |
| Scientific Title | efficacy and safety of Gemcitabine plus nab-paclitaxel in unresectable pancreas cancer |
| Date of disclosure of the study information | 2014/02/20 |
| Last modified on | 2022/02/26 10:37:05 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/02/20 14:54:23 | ||
| 2 | Update | 2014/12/22 19:18:50 | Key secondary outcomes Key secondary outcomes |
|
| 3 | Update | 2014/12/22 19:38:07 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 4 | Update | 2014/12/22 19:39:10 | Recruitment status |
|
| 5 | Update | 2016/09/17 10:32:02 | Control |
|
| 6 | Update | 2016/09/17 10:33:09 | Name of primary person or sponsor Organization Organization Organization |
|
| 7 | Update | 2021/03/05 16:13:45 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Institute Email3 Organization Organization Address Address Tel |
|
| 8 | Update | 2022/02/26 10:36:38 | Recruitment status Date of IRB Last follow-up date |
|
| 9 | Update | 2022/02/26 10:37:05 | Number of participants that the trial has enrolled |
